Both in Pharmaceuticals
Cellectar Biosciences INC NEW vs Tvardi Therapeutics
Over the past year CLRB returned −66.4% and TVRD returned −96.5%; their daily moves had a correlation of -0.03.
CLRB −66.4% TVRD −96.5%Growth of $1, one year, split-adjusted
| Metric | CLRB | TVRD |
|---|---|---|
| Price | $1.82 | $1.28 |
| Market cap | $17.2M | $17.1M |
| Today | −0.55% | −3.76% |
| 1 month | −28.1% | −29.7% |
| 6 months | −30.3% | −60.0% |
| Year to date | −38.3% | −70.2% |
| 1 year | −67.0% | −96.5% |
| Revenue growth (YoY) | — | — |
| Gross margin | — | — |
| Net margin | — | — |
| P/E (TTM) | — | — |
| Price / sales | — | — |
| Net cash | $34.0M | $15.8M |
| Dividend yield | — | — |
| Volatility (60d) | 46.2% | 172.8% |
| Short % of float | 2.5% | 4.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).